BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDBB

BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USD

19.300USDD
+0.100+0.52%
At close at Feb 24, 22:12 GMT
USD
No trades
See on Supercharts

BMYD fundamentals

Key facts

Market capitalization‪117.46 B‬USD
Basic EPS (TTM)−1.16USD
Founded1933
Employees (FY)‪34.1 K‬
CEOChristopher S. Boerner
Websitebms.com
About

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪117.46 B‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
2.81x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
2.81x
Valuation ratios
‪0.00‬
‪2.00‬
‪4.00‬
‪6.00‬
‪8.00‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪12.00‬
‪24.00‬
‪36.00‬
‪48.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−105%‬
‪−70%‬
‪−35%‬
‪0%‬
‪35%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−12.00 B‬‬
‪‪−6.00 B‬‬
‪0.00‬
‪‪6.00 B‬‬
‪‪12.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Innovative Medicines
By country
Period: 2024
United States
International
Global

Dividends

Dividend yield, history and sustainability

Dividend summary
−47.98%
Payout ratio (TTM)
Dividend yield TTM
2.52%
Last payment
0.131
Last ex-date
Jan 3, 2025
Dividend history
‪0.75%‬
‪1.25%‬
‪1.75%‬
‪2.25%‬
‪2.75%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.15‬
‪0.30‬
‪0.45‬
‪0.60‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪15.00 B‬‬
‪‪30.00 B‬‬
‪‪45.00 B‬‬
‪‪60.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪16.00 B‬‬
‪‪32.00 B‬‬
‪‪48.00 B‬‬
‪‪64.00 B‬‬
Assets
Liabilities